Citations

Showing 10 of 108083 citations.

Spigelman IV: can intensive cold snaring avoid duodenectomy in familial adenomatous polyposis?
East, James E. , East, James E

Mayo Clinic

Endoscopy | February 9, 2023 | Volume: 55 | Issue: 06 | Pages: 524-525

10.1055/a-2018-4712 | PMID 36758583 Get It

SVM Communications: Increasing awareness of vascular medicine as a specialty
Brunton, Nichole , Tomihama, Roger T. , Henkin, Stanislav , Tomihama, Roger , Henkin, Stanislav , Brunton, Nichole E

Mayo Clinic

Vascular Medicine | February 9, 2023 | Volume: 28 | Issue: 1 | Pages: 97-98

10.1177/1358863x221146588 | PMID 36759933 Get It

Update in the understanding of new daily persistent headache
Peng, Kuan‐Po , Rozen, Todd D.

Mayo Clinic

Cephalalgia | February 9, 2023 | Volume: 43 | Issue: 2 | Pages: No page available

10.1177/03331024221146314 | PMID 36759317 Get It

Background Accumulating evidence suggests various specific triggers may lead to new daily persistent headache (NDPH)-like presentations, suggesting that new daily persistent headache is a heterogenous syndrome, and challenging the concept that new daily persistent headache is a primary headache disorder. Method We searched the PubMed database up to August 2022 for keywords including persistent daily headache with both primary and secondary etiologies. We summarized the literature and provided a narrative review of the clinical presentation, diagnostic work-ups, possible pathophysiology, treatment response, and clinical outcomes. Results and conclusion New daily persistent headache is a controversial but clinically important topic. New daily persistent headache is likely not a single entity but a syndrome with different etiologies. The issue with past studies of new daily persistent headache is that patients with different etiologies/subtypes were pooled together. Different studies may investigate distinct subsets of patients, which renders the inter-study comparison, both positive and negative results, difficult. The identification (and removal) of a specific trigger might provide the opportunity for clinical improvement in certain patients, even when the disease has lasted for months or years. Nonetheless, if there is a specific trigger, it remains unknown or unidentified for a great proportion of the patients. We need to continue to study this unique headache population to better understand underlying pathogenesis and, most importantly, to establish effective treatment strategies that hopefully resolve the continuous cycle of pain.
Assessing Patients and Care Partner Ratings of Communication-Related Participation Restrictions: Insights From Degenerative Disease
Utianski, Rene L. , Martin, Peter R. , Duffy, Joseph R. , Clark, Heather M. , Stierwalt, Julie A. G., Botha, Hugo , Ali, Farwa , Whitwell, Jennifer L. , Josephs, Keith A. , Utianski, Rene L , Botha, Hugo , Clark, Heather M , Duffy, Joseph R , Whitwell, Jennifer L.

Mayo Clinic

American Journal of Speech-Language Pathology | February 9, 2023 | Volume: 32 | Issue: 4S | Pages: 1793-1805

10.1044/2022_ajslp-22-00140 | PMID 36758199 Get It

Purpose: Prior studies have shown that communication-related participation restrictions in patients with degenerative disease do not always match clinician judgment or objective indices of symptom severity. Although there is a growing body of literature documenting that discrepancies between patients with dementia and their care partners' perception of participation restrictions exist, it is not known how care partner perceptions of communication participation restrictions specifically match or diverge from the patients' experiences, which may inform the use of care partner proxy in the context of degenerative diseases. Method: Thirty-eight patients with progressive neurologic conditions (progressive supranuclear palsy, corticobasal syndrome, and primary progressive aphasia or apraxia of speech) and, in most instances, focal cognitive-communication disorders were included. The patients and their accompanying care partners independently completed the Communicative Participation Item Bank, short form, a 10-question survey about communication participation restrictions in different contexts. Care partners were instructed to complete the form with their perception of the patient's experience. The difference between patient and care partner total scores were calculated and analyzed relative to clinical and demographic variables of interest. Results: Care partner ratings modestly tracked with patient experience and objective indices of symptom severity but did not exactly match patient ratings. The presence of aphasia increased, but did not fully account for, the likelihood of a discrepancy between care partner and patient ratings. Conclusion: Although careful consideration should be given prior to using care-partner report as a proxy for patient experience, it is worthwhile to include care partner ratings as a means of supporting conversations about differing perceptions, guiding joint intervention planning, and monitoring care-partner perceptions of change along with the implementation of supported conversation strategies.
Clinical Administration Characteristics of Subcutaneous and Intravenous Administration of Daratumumab in Patients With Multiple Myeloma at Mayo Clinic Infusion Centers
Soefje, Scott A. , Carpenter, Corinne , Carlson, Katherine , Awasthi, Samir , Lin, Thomas S., Kaila, Shuchita, Tarjan, Daniel R., Kayal, Nikhil , Kirkup, Christian , Wagner, Tyler E. , Gray, Kathleen, Kumar, Shaji , Soefje, Scott A , Tarjan, Daniel, Wagner, Tyler E

Mayo Clinic

JCO Oncology Practice | February 9, 2023 | Volume: 19 | Issue: 4 | Pages: e542-e549

10.1200/op.22.00421 | PMID 36758192 Get It

PURPOSE: Median duration of daratumumab (DARA) administration for treatment of multiple myeloma is 3-7 hours for the intravenous formulation (DARA IV) and 3-5 minutes for the subcutaneous formulation (DARA SC). Here, we describe clinical administration characteristics of DARA using a novel method for data extraction from electronic health records. METHODS: Time-based measurements were extracted using a scheduling/pharmacy software program that tracked patient movement through appointments for patients initiating DARA in Mayo Clinic infusion centers from April 5, 2017, to October 14, 2021. Cohorts included patients who received DARA IV or DARA SC, or converted from DARA IV to DARA SC. The DARA SC cohort was further analyzed before (DARA SC initial) and after (DARA SC shortened) a reduction in the postadministration observation time mandated by the treatment plan. Events associated with administration-related reactions (ARRs) were also identified. RESULTS: Median total clinic times were 2.7-3.0 hours shorter for DARA SC versus DARA IV. Median clinic times were highest at dose 1 and decreased with subsequent doses. Median total chair times were 2.7-2.8 hours shorter for DARA SC versus DARA IV. Incidences of ARR-related events with DARA SC were low across doses. CONCLUSION: Reduced clinic times were observed with DARA SC, indicating that use of DARA SC as a treatment option results in time savings that may free clinic resources. Furthermore, novel methods of electronic health record data extraction can provide insights that may help inform clinic resource optimization.
Comparing Linear and Volumetric Tumor Measurements During Observation of Growing Sporadic Vestibular Schwannomas
Killeen, Daniel E. , Marinelli, John P. , Lohse, Christine M. , Lees, Katherine A. , Link, Michael J. , Carlson, Matthew L. , Hunter, Jacob B.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | February 9, 2023 | Volume: 169 | Issue: 3 | Pages: 633-641

10.1002/ohn.290 | PMID 36758946 Get It

AbstractObjectiveTo assess the correlation between linear and volumetric changes in vestibular schwannomas (VS).Study DesignRetrospective imaging review was performed on patients diagnosed with sporadic VS from 2000 to 2019 who demonstrated linear growth on observation with serial magnetic resonance imaging (MRI).SettingTwo large tertiary care centers.MethodsChanges in diameter on serial MRI scans, measured by 1995 American Academy of Otolaryngology‐Head and Neck Surgery guidelines, were compared to changes in volume, calculated by segmentation.ResultsNinety‐two patients had VS confined to the internal auditory canal (IAC) with 236 MRIs analyzed, and 108 patients had VS involving the cerebellopontine angle (CPA) with 193 MRIs analyzed. The Spearman rank correlation coefficients between changes in diameter and volume for IAC and CPA tumors were 0.43 (p < .001) and 0.65 (p < .001), respectively. Linear diameter increases of 1 to <2 mm corresponded to a median volume change of 32% (interquartile range [IQR]: 6%‐86%) for IAC tumors, compared to 23% (IQR: 13%‐40%) for CPA tumors. Linear diameter increases of 2 to <3 mm (ie, the minimum linear diameter change classically considered “true growth”) corresponded to a median volume change of 42% (IQR: 23%‐100%) and 47% (IQR: 26%‐69%) for IAC and CPA tumors, respectively.ConclusionChanges in linear diameter significantly correlated with changes in volume for IAC and CPA tumors, although diameter changes that did not meet the definition of linear growth (<2 mm) had corresponding median volume changes in excess of 20% for both IAC and CPA tumors.
Evaluation of Scapholunate Injury and Repair with Dynamic (4D) CT: A Preliminary Report of Two Cases
Zhao, Kristin D. , Lopez, Cesar , Fautsch, Kalli J., Holmes, David R. , Moran, Steven L. , Thoreson, Andrew R. , Trentadue, Taylor P. , Trentadue, Taylor P , Fautsch, Kalli, Holmes Iii, David R, Trentadue, Taylor P , Breighner, Ryan , Leng, Shuai , III, David R. Holmes, Kakar, Sanjeev

Mayo Clinic

Journal of Wrist Surgery | February 9, 2023 | Volume: 12 | Issue: 03 | Pages: 248-260

10.1055/s-0042-1758159 | PMID 37223378 Get It

Abstract Background In predynamic or dynamic scapholunate (SL) instability, standard diagnostic imaging may not identify SL interosseous ligament (SLIL) injury, leading to delayed detection and intervention. This study describes the use of four-dimensional computed tomography (4DCT) in identifying early SLIL injury and following injured wrists to 1-year postoperatively. Description of Technique 4DCT acquires a series of three-dimensional volume data with high temporal resolution (66 ms). 4DCT-derived arthrokinematic data can be used as biomarkers of ligament integrity. Patients and Methods This study presents the use of 4DCT in a two-participant case series to assess changes in arthrokinematics following unilateral SLIL injury preoperatively and 1-year postoperatively. Patients were treated with volar ligament repair with volar capsulodesis and arthroscopic dorsal capsulodesis. Arthrokinematics were compared between uninjured, preoperative injured, and postoperative injured (repaired) wrists. Results 4DCT detected changes in interosseous distances during flexion-extension and radioulnar deviation. Generally, radioscaphoid joint distances were greatest in the uninjured wrist during flexion-extension and radioulnar deviation, and SL interval distances were smallest in the uninjured wrist during flexion-extension and radioulnar deviation. Conclusion 4DCT provides insight into carpal arthrokinematics during motion. Distances between the radioscaphoid joint and SL interval can be displayed as proximity maps or as simplified descriptive statistics to facilitate comparisons between wrists and time points. These data offer insight into areas of concern for decreased interosseous distance and increased intercarpal diastasis. This method may allow surgeons to assess whether (1) injury can be visualized during motion, (2) surgery repaired the injury, and (3) surgery restored normal carpal motion. Level of Evidence Level IV, Case series.
The value of embedded palliative care in the emergency department
Neugarten, Carter , Baldeo, Ryan , Tian, Katherine, Piscitello, Gina M. , O’Mahony, Sean , Kaginele, Pranita , Wang, David H., Tian, Katherine

Mayo Clinic

Academic Emergency Medicine | February 9, 2023 | Volume: 30 | Issue: 8 | Pages: 870-873

10.1111/acem.14684 | PMID 36757676 Get It

Clinical advances: pregnancy in gastroenterologic and hepatic conditions
Kane, Sunanda V. , Reau, Nancy

Mayo Clinic

Gut | February 9, 2023 | Volume: 72 | Issue: 5 | Pages: 1007-1015

10.1136/gutjnl-2022-328893 | PMID 36759153 Get It

The fields of gastroenterology and hepatology, along with endoscopic practice, have seen significant changes and innovations to practice in just the past few years. These practice changes are not limited to gastroenterology, but maternal fetal medicine and the care of the pregnant person have become increasingly more sophisticated as well. Gastroenterologists are frequently called on to provide consultative input and/or perform endoscopy during pregnancy. To be able to provide the best possible care to these patients, gastroenterologists need to be aware of (and familiar with) the various nuances and caveats related to the care of pregnant patients who either have underlying gastrointestinal (GI) conditions or present with GI and liver disorders. Here, we offer a clinical update with references more recent than 2018, along with a few words about SARS-CoV-2 infection and its relevance to pregnancy.
Hypofractionation and SABR: 25 years of evolution in medical physics and a glimpse of the future
Ding, Xuanfeng , Daly, Megan E. , Rong, Yi

Mayo Clinic

Medical Physics | February 9, 2023 | Volume: 50 | Issue: S1 | Pages: 95-103

10.1002/mp.16270 | PMID 36756953 Get It

AbstractAs we were invited to write an article for celebrating the 50th Anniversary of Medical Physics journal, on something historically significant, commemorative, and exciting happening in the past decades, the first idea came to our mind is the fascinating radiotherapy paradigm shift from conventional fractionation to hypofractionation and stereotactic ablative radiotherapy (SABR). It is historically and clinically significant since as we all know this RT treatment revolution not only reduces treatment duration for patients, but also improves tumor control and cancer treatment outcomes. It is also commemorative and exciting for us medical physicists since the technology development in medical physics has been the main driver for the success of this treatment regimen which requires high precision and accuracy throughout the entire treatment planning and delivery. This article provides an overview of the technological development and clinical trials evolvement in the past 25 years for hypofractionation and SABR, with an outlook to the future improvement.